Breaking News Instant updates and real-time market news.

CBSH

Commerce Bancshares

$58.45 /

+0.15 (+0.26%)

06:04
10/20/20
10/20
06:04
10/20/20
06:04

Commerce Bancshares reports Q3 EPS $1.11, consensus 7c

Reports Q3 Net loan charge-offs $7.6M, compared to $8.4M in the prior quarter. In announcing these results, John Kemper, Chief Executive Officer, said, "We are pleased to report a healthy rebound in earnings this quarter. Net income grew significantly compared to the Q2, driven by low provision expense and by increases in net interest income, fee income, and investment securities gains. Compared to the prior quarter, net interest income grew $12.9Msupported by our larger balance sheet and historically low funding costs. Fee income from our bank card, trust and mortgage banking businesses rebounded nicely from the prior quarter. While our bank card fees have not yet fully recovered from the impact of COVID-19, trust and mortgage banking fees were at record levels. Prudent expense management remains in focus as we prepare for a prolonged low interest rate environment. We continued our efforts of providing relief to customers who have been impacted by COVID-19. Loans on active deferral declined significantly throughout the quarter. Fewer customers requested first-time relief, and just a small percentage of our customers required extensions of their initial relief requests. We remain cautiously optimistic about the recovery of the economy and are encouraged by the resiliency of our customers and communities."

CBSH Commerce Bancshares
$58.45 /

+0.15 (+0.26%)

06/17/20 Raymond James
Commerce Bancshares downgraded to Underperform from Market Perform at Raymond James
06/17/20 Raymond James
Commerce Bancshares downgraded to Underperform from Market Perform at Raymond James
04/06/20 Raymond James
Commerce Bancshares upgraded to Market Perform from Underperform at Raymond James
04/06/20 Raymond James
Commerce Bancshares upgraded to Market Perform at Raymond James

TODAY'S FREE FLY STORIES

General news
FX Action: USD-CAD has lifted above Monday's high » 04:05
04/13/21
04/13
04:05
04/13/21
04:05
$ECON

Economic Data

/

+

FX Action: USD-CAD has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    General news
    FX Update: The dollar picked up » 03:45
    04/13/21
    04/13
    03:45
    04/13/21
    03:45
    $ECON

    Economic Data

    /

    +

    FX Update: The dollar…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
      General news
      Asian Market Update: » 01:55
      04/13/21
      04/13
      01:55
      04/13/21
      01:55
      $ECON

      Economic Data

      /

      +

      Asian Market Update:…

      Asian Market Update: Treasury yields have moved higher as key U.S. CPI readings start to come into view, with reflation trades and concern that the Fed may be forced to act earlier and more decisive than planned, weighing on bond markets and also keeping a lid on stocks. The U.S. 10-year rate is currently up 2.7 bp at 1.69% and bonds were also mostly under pressure across Asia, although China's official rates dropped after export growth missed expectations, even as they jumped 30.6%. Import growth meanwhile surged to 38.1%, which meant the trade surplus narrowed sharply. Stock markets traded mixed, across Asia, after a cautious session on Wall Street yesterday. Topix and Nikkei gained 0.3% and 0.7% respectively, but the ASX was down -0.1% at the close. The Hang Seng is currently up 0.3%, but the CSI 300 down -0.3%. In FX markets the yen weakened, while the dollar was mostly higher, leaving USD-JPY at 109.70. The front end WTI future meanwhile is trading at USD 59.91 per barrel.

      ShowHide Related Items >><<
        General news
        U.S. CPI preview » 01:55
        04/13/21
        04/13
        01:55
        04/13/21
        01:55
        $ECON

        Economic Data

        /

        +

        U.S. CPI preview:…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return tomorrow

        Get Free Trial

        ShowHide Related Items >><<
          Recommendations
          Reviews of Tela Bio's OviTex from two KOLs were positive, says Piper Sandler » 20:58
          04/12/21
          04/12
          20:58
          04/12/21
          20:58
          TELA

          Tela Bio

          $13.58 /

          + (+0.00%)

          Piper Sandler analyst…

          Piper Sandler analyst Matt O'Brien keeps his Overweight rating and $20 price target on Tela Bio after the company-hosted investor call featuring two key opinion leaders discussing their use of the company's OviTex in treating hernias. The clinicians used the product in hundreds of procedures ranging from simple cases to complex procedures, the analyst tells investors in a research note, adding that he was "struck by the enthusiasm" that both of the surgeons had for the product and the low recurrence rates in procedures using OviTex compared to competitive meshes.

          ShowHide Related Items >><<
          TELA Tela Bio
          $13.58 /

          + (+0.00%)

          TELA Tela Bio
          $13.58 /

          + (+0.00%)

          04/01/21 Piper Sandler
          Integra to benefit from FDA safety communication, says Piper Sandler
          03/25/21 Canaccord
          Tela Bio pieces in place for accelerating growth, says Canaccord
          01/14/21 Piper Sandler
          Piper says Tela Bio momentum looks 'healthy' despite 'slight' Q4 miss
          11/11/20 Piper Sandler
          Tela Bio price target raised to $20 from $17 at Piper Sandler
          TELA Tela Bio
          $13.58 /

          + (+0.00%)

          • 26
            Jun
          Recommendations
          New CEO at Amarin to facilitate continued growth, says Piper Sandler » 20:53
          04/12/21
          04/12
          20:53
          04/12/21
          20:53
          AMRN

          Amarin

          $5.85 /

          -0.09 (-1.52%)

          Piper Sandler analyst…

          Piper Sandler analyst Yasmeen Rahimi keeps her Overweight rating and $19 price target on Amarin after the company announced that Karim Mikhail would succeed John Thero as CEO later this year. The Street was surprised by the announcement, the analyst tells investors in a research note, but she believes that his deep commercial expertise will facilitate Amarin's continued growth, especially ahead of VAZKEPA's E.U. launch in Q3 of this year.

          ShowHide Related Items >><<
          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          04/06/21 Piper Sandler
          Amarin 'one step closer' to multi-billion opportunity, says Piper Sandler
          02/25/21 Piper Sandler
          Amarin to have strong execution year ahead, says Piper Sandler
          02/01/21 Piper Sandler
          Matinas trial shows 'robust' serum increass despite miss, says Piper Sandler
          01/29/21 Piper Sandler
          Amarin's EU approval 'guaranteed' after CHMP nod, says Piper Sandler
          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          AMRN Amarin
          $5.85 /

          -0.09 (-1.52%)

          Downgrade
          NorthWestern downgraded to Neutral from Outperform at Credit Suisse » 20:46
          04/12/21
          04/12
          20:46
          04/12/21
          20:46
          NWE

          NorthWestern

          $67.70 /

          +0.79 (+1.18%)

          Credit Suisse analyst…

          Credit Suisse analyst Michael Weinstein downgraded NorthWestern to Neutral from Outperform with a price target of $66, up from $60. The analyst says his rating change is driven by valuation following the recent period of outperformance in the stock.

          ShowHide Related Items >><<
          NWE NorthWestern
          $67.70 /

          +0.79 (+1.18%)

          NWE NorthWestern
          $67.70 /

          +0.79 (+1.18%)

          03/23/21 BofA
          NorthWestern upgraded to Neutral from Underperform at BofA
          12/04/20
          Fly Intel: Top five analyst initiations
          12/04/20 KeyBanc
          NorthWestern initiated with an Overweight at KeyBanc
          11/18/20 Barclays
          NorthWestern downgraded to Equal Weight from Overweight at Barclays
          NWE NorthWestern
          $67.70 /

          +0.79 (+1.18%)

          Upgrade
          MFA Financial upgraded to Outperform from Market Perform at Keefe Bruyette » 20:43
          04/12/21
          04/12
          20:43
          04/12/21
          20:43
          MFA

          MFA Financial

          $4.18 /

          +0.005 (+0.12%)

          Keefe Bruyette analyst…

          Keefe Bruyette analyst Bose George upgraded MFA Financial to Outperform from Market Perform with a $4.75 price target.

          ShowHide Related Items >><<
          MFA MFA Financial
          $4.18 /

          +0.005 (+0.12%)

          11/23/20 BTIG
          MFA Financial initiated with a Buy at BTIG
          08/24/20 JMP Securities
          MFA Financial upgraded to Outperform from Market Perform at JMP Securities
          08/24/20 JMP Securities
          MFA Financial upgraded to Outperform from Market Perform at JMP Securities
          04/13/20 JMP Securities
          MFA Financial downgraded to Market Perform from Outperform at JMP Securities
          MFA MFA Financial
          $4.18 /

          +0.005 (+0.12%)

          MFA MFA Financial
          $4.18 /

          +0.005 (+0.12%)

          Downgrade
          Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital » 20:42
          04/12/21
          04/12
          20:42
          04/12/21
          20:42
          CADE

          Cadence Bancorp

          $22.41 /

          +0.92 (+4.28%)

          RBC Capital analyst Jon…

          RBC Capital analyst Jon Arfstrom downgraded Cadence Bancorp to Sector Perform from Outperform with a $25 price target.

          ShowHide Related Items >><<
          CADE Cadence Bancorp
          $22.41 /

          +0.92 (+4.28%)

          CADE Cadence Bancorp
          $22.41 /

          +0.92 (+4.28%)

          02/23/21 Stephens
          Stephens raises Regions price target to $23, sees possible deal for Cadence
          08/18/20 Keefe Bruyette
          Cadence Bancorp upgraded to Outperform from Market Perform at Keefe Bruyette
          08/14/20 Truist
          Cadence Bancorp upgraded to Buy from Hold at Truist
          08/14/20 Truist
          Cadence Bancorp upgraded to Buy from Hold at Truist
          CADE Cadence Bancorp
          $22.41 /

          +0.92 (+4.28%)

          CADE Cadence Bancorp
          $22.41 /

          +0.92 (+4.28%)

          Initiation
          Identiv initiated with a Buy at B. Riley » 20:29
          04/12/21
          04/12
          20:29
          04/12/21
          20:29
          INVE

          Identiv

          $11.75 /

          +0.25 (+2.17%)

          B. Riley analyst Craig…

          B. Riley analyst Craig Ellis initiated coverage of Identiv with a Buy rating and $21 price target.

          ShowHide Related Items >><<
          INVE Identiv
          $11.75 /

          +0.25 (+2.17%)

          INVE Identiv
          $11.75 /

          +0.25 (+2.17%)

          09/28/20 Northland
          Identiv benefitting as Apple supports NFC, says Northland
          09/22/20 Lake Street
          Identiv price target raised to $8 after management meeting at Lake Street
          INVE Identiv
          $11.75 /

          +0.25 (+2.17%)

          • 08
            Apr
          Hot Stocks
          Lyft CFO sells 15K shares of common stock » 20:27
          04/12/21
          04/12
          20:27
          04/12/21
          20:27
          LYFT

          Lyft

          $59.82 /

          -1.14 (-1.87%)

          In a regulatory filing,…

          In a regulatory filing, Lyft disclosed that its CFO Brian Roberts sold 15K shares of common stock on April 8th in a total transaction size of $919.9K, reducing his stake by about 1%.

          ShowHide Related Items >><<
          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          04/05/21 Evercore ISI
          Lyft assumed with an Outperform at Evercore ISI
          03/31/21 Wolfe Research
          Lyft assumed with a Peer Perform at Wolfe Research
          03/26/21
          Fly Intel: Top five analyst initiations
          03/26/21 Vertical Research
          Lyft initiated with a Buy at Vertical Research
          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          LYFT Lyft
          $59.82 /

          -1.14 (-1.87%)

          Upgrade
          FedEx upgraded to Overweight from Sector Weight at KeyBanc » 20:25
          04/12/21
          04/12
          20:25
          04/12/21
          20:25
          FDX

          FedEx

          $290.86 /

          +4.335 (+1.51%)

          KeyBanc analyst Todd…

          KeyBanc analyst Todd Fowler upgraded FedEx to Overweight from Sector Weight with a $350 price target. The analyst is citing the proprietary Online Parcel Index suggesting that B2C parcel volumes remained strong throughout Q1. Fowler adds that the positive trends around more resilient airfreight dynamics, leverage to improving global economic activity, and rational pricing dynamics should persist and "more than offset" any potential impact from a return to in-person shopping and service spending.

          ShowHide Related Items >><<
          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          04/12/21 KeyBanc
          FedEx upgraded to Overweight from Sector Weight at KeyBanc
          04/08/21 JPMorgan
          FedEx added to Analyst Focus List as value idea at JPMorgan
          03/26/21
          Fly Intel: Top five analyst initiations
          03/26/21 Vertical Research
          FedEx initiated with a Buy at Vertical Research
          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          Hot Stocks
          Innovent/Eli Lilly's phase 3 study of TYVYT in sqNSCLC saw OS improvement » 20:05
          04/12/21
          04/12
          20:05
          04/12/21
          20:05
          IVBXF

          Innovent Biologics

          $13.00 /

          + (+0.00%)

          , LLY

          Eli Lilly

          $181.76 /

          -2.71 (-1.47%)

          Innovent Biologics…

          Innovent Biologics (IVBXF) announced with Eli Lilly (LLY) that the results of the Phase 3 ORIENT-3 study were released today in an oral presentation at the American Association for Cancer Research Annual Meeting 2021. ORIENT-3 is a randomized, open-label, Phase 3 clinical trial evaluating TYVYT, or sintilimab injection, versus docetaxel as a second-line treatment for advanced or metastatic squamous non-small cell lung cancer, or sqNSCLC. A total of 290 patients whose cancer had progressed following first-line treatment with platinum-based chemotherapy were enrolled. Based on the primary analysis population, TYVYT demonstrated a statistically significant improvement in overall survival, or OS, compared to docetaxel, meeting the pre-specified primary endpoint. The median OS was 11.79 months for patients on the TYVYT arm and 8.25 months for those on the docetaxel arm. The median progression-free survival as assessed by investigators was 4.30 months versus 2.79 months, and the confirmed objective response rate was 25.5% versus 2.2%, respectively. Safety was consistent with previous studies of TYVYT, and no new safety signals were identified.

          ShowHide Related Items >><<
          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          IVBXF Innovent Biologics
          $13.00 /

          + (+0.00%)

          11/03/20 Daiwa
          Innovent Biologics initiated with a Buy at Daiwa
          07/08/20 JPMorgan
          Innovent Biologics downgraded to Neutral from Overweight at JPMorgan
          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          04/12/21 Benchmark
          Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
          04/06/21 JPMorgan
          JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
          03/24/21 BMO Capital
          AbCellera price target lowered to $59 from $61 at BMO Capital
          03/17/21 Mizuho
          AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          LLY Eli Lilly
          $181.76 /

          -2.71 (-1.47%)

          Hot Stocks
          Opendoor Technologies up 1.5% afterhours after ARK Investment ETF trade update » 19:33
          04/12/21
          04/12
          19:33
          04/12/21
          19:33
          OPEN

          Opendoor Technologies

          $19.40 /

          -1.1 (-5.37%)

          Shares of Opendoor…

          Shares of Opendoor Technologies are up 1.5% afterhours at $19.70. In its daily evening update, ARK Investment Management disclosed a Buy of 633.4K shares of common stock.

          ShowHide Related Items >><<
          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          03/18/21
          Fly Intel: Top five analyst initiations
          03/18/21 Citi
          Opendoor Technologies initiated with a Buy at Citi
          03/05/21 Oppenheimer
          Opendoor Technologies price target lowered to $30 from $34 at Oppenheimer
          03/01/21 Credit Suisse
          Opendoor Technologies initiated with an Outperform at Credit Suisse
          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          • 05
            Feb
          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          OPEN Opendoor Technologies
          $19.40 /

          -1.1 (-5.37%)

          Upgrade
          FedEx upgraded to Overweight from Sector Weight at KeyBanc » 19:25
          04/12/21
          04/12
          19:25
          04/12/21
          19:25
          FDX

          FedEx

          $290.86 /

          +4.335 (+1.51%)

          KeyBanc analyst Todd…

          KeyBanc analyst Todd Fowler upgraded FedEx to Overweight from Sector Weight.

          ShowHide Related Items >><<
          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          04/08/21 JPMorgan
          FedEx added to Analyst Focus List as value idea at JPMorgan
          03/26/21
          Fly Intel: Top five analyst initiations
          03/26/21 Vertical Research
          FedEx initiated with a Buy at Vertical Research
          03/22/21 Argus
          FedEx underperformance offers buying opportunity, says Argus
          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          FDX FedEx
          $290.86 /

          +4.335 (+1.51%)

          Hot Stocks
          Agilent CEO sells 15,095 shares of common stock » 19:20
          04/12/21
          04/12
          19:20
          04/12/21
          19:20
          A

          Agilent

          $131.25 /

          -0.635 (-0.48%)

          In a regulatory filing,…

          In a regulatory filing, Agilent disclosed that its CEO Michael McMullen sold 15,095 shares of common stock on April 8th in a total transaction size of $1.97M, reducing his stake by about 5%.

          ShowHide Related Items >><<
          A Agilent
          $131.25 /

          -0.635 (-0.48%)

          A Agilent
          $131.25 /

          -0.635 (-0.48%)

          03/18/21
          Fly Intel: Top five analyst upgrades
          03/18/21 Citi
          Agilent upgraded to Buy from Neutral at Citi
          03/18/21 Citi
          Agilent upgraded to Buy from Neutral at Citi
          02/17/21 Baird
          Agilent price target raised to $137 from $133 at Baird
          A Agilent
          $131.25 /

          -0.635 (-0.48%)

          A Agilent
          $131.25 /

          -0.635 (-0.48%)

          A Agilent
          $131.25 /

          -0.635 (-0.48%)

          Hot Stocks
          Mesa Air reports 28.1K block hours in March, down 15.9% from last year » 19:05
          04/12/21
          04/12
          19:05
          04/12/21
          19:05
          MESA

          Mesa Air

          $12.38 /

          -0.58 (-4.48%)

          Mesa Air Group reported…

          Mesa Air Group reported Mesa Airlines' operating performance for March 2021. Mesa Airlines reported 28,127 block hours in March 2021, a 15.9% drop from March 2020 "as a result of reduced schedules during the COVID-19 pandemic. The company also reported a controllable completion factor of 99.86 percent and 100 percent for its American and United operations, respectively. For Q2 of fiscal year 2021 ending March 31st, total block hours were 73,942 on 35,270 departures. These block hours are well below our guidance provided on our Q1 fiscal year 2021 Earnings Release. The reduced block hours and departures were the result of the mid-February major winter storm and subsequent Texas power outages impacting our major operations in both Dallas and Houston. During that period, we cancelled almost 1,300 flights representing close to 3,000 block hours while still incurring crew costs."

          ShowHide Related Items >><<
          MESA Mesa Air
          $12.38 /

          -0.58 (-4.48%)

          MESA Mesa Air
          $12.38 /

          -0.58 (-4.48%)

          03/04/21
          Fly Intel: Top five analyst downgrades
          03/04/21 Deutsche Bank
          Mesa Air downgraded to Hold after 100% rally at Deutsche Bank
          03/03/21 Deutsche Bank
          Mesa Air downgraded to Hold from Buy at Deutsche Bank
          02/17/21
          Fly Intel: Top five analyst upgrades
          MESA Mesa Air
          $12.38 /

          -0.58 (-4.48%)

          MESA Mesa Air
          $12.38 /

          -0.58 (-4.48%)

          MESA Mesa Air
          $12.38 /

          -0.58 (-4.48%)

          Initiation
          Tetra Tech initiated with a Hold at Vertical Research » 18:56
          04/12/21
          04/12
          18:56
          04/12/21
          18:56
          TTEK

          Tetra Tech

          $143.60 /

          +0.87 (+0.61%)

          Vertical Research analyst…

          Vertical Research analyst Michael Dudas initiated coverage of Tetra Tech with a Hold rating and $145 price target.

          ShowHide Related Items >><<
          TTEK Tetra Tech
          $143.60 /

          +0.87 (+0.61%)

          TTEK Tetra Tech
          $143.60 /

          +0.87 (+0.61%)

          02/01/21 Roth Capital
          Tetra Tech price target raised to $135 from $98 at Roth Capital
          01/15/21 Maxim
          Tetra Tech price target raised to $155 from $140 at Maxim
          11/12/20 Maxim
          Tetra Tech price target raised to $135 from $110 at Maxim
          11/09/20 Stifel
          Tetra Tech upgraded to Buy from Hold at Stifel
          TTEK Tetra Tech
          $143.60 /

          +0.87 (+0.61%)

          TTEK Tetra Tech
          $143.60 /

          +0.87 (+0.61%)

          Hot Stocks
          Air Canada enters into debt, equity financing agreement with Canadian government » 18:54
          04/12/21
          04/12
          18:54
          04/12/21
          18:54
          ACDVF

          Air Canada

          $21.53 /

          +0.1401 (+0.65%)

          Air Canada announced that…

          Air Canada announced that it has entered into a series of debt and equity financing agreements with the Government of Canada, which will allow Air Canada to access up to C$5.879B in liquidity through the Large Employer Emergency Financing Facility program. "Air Canada entered the pandemic more than a year ago with one of the global airline industry's strongest balance sheets relative to its size. We have since raised an additional $6.8 billion in liquidity from our own resources to sustain us through the pandemic, as air traffic ground to a virtual halt in Canada and internationally," said Michael Rousseau, President and Chief Executive Officer of Air Canada. "The additional liquidity program we are announcing today achieves several aligned objectives as it provides a significant layer of insurance for Air Canada, it enables us to better resolve customer refunds of non-refundable tickets, maintain our workforce and re-enter regional markets. Most importantly, this program provides additional liquidity, if required, to rebuild our business to the benefit of all stakeholders and to remain a significant contributor to the Canadian economy through its recovery and for the long term. As vaccine deployments ramp up, we continue to work with the Government of Canada on the evolution of safe and science-based test and quarantine relief measures with a view to safely restarting our sector. We know that Canadians are looking forward to re-connecting with friends and family and taking those long-awaited vacations and business trips and we will be ready to safely connect Canadians within Canada and Canada to the world," said Rousseau.

          ShowHide Related Items >><<
          ACDVF Air Canada
          $21.53 /

          +0.1401 (+0.65%)

          ACDVF Air Canada
          $21.53 /

          +0.1401 (+0.65%)

          04/09/21 CIBC
          Air Canada price target raised to C$34 from C$28 at CIBC
          04/08/21 National Bank
          Air Canada downgraded to Sector Perform from Outperform at National Bank
          03/16/21 TD Securities
          Air Canada downgraded to Hold from Buy at TD Securities
          03/12/21 Scotiabank
          Air Canada downgraded to Sector Perform from Outperform at Scotiabank
          ACDVF Air Canada
          $21.53 /

          +0.1401 (+0.65%)

          Hot Stocks
          FDA grants Akouos orphan drug designation in OTOF-mediated hearing loss » 18:54
          04/12/21
          04/12
          18:54
          04/12/21
          18:54
          AKUS

          Akouos

          $14.52 /

          +0.66 (+4.76%)

          On a post on the…

          On a post on the FDA's website, Akouos' treatment for otoferlin gene (OTOF)-mediated hearing loss was granted orphan drug designation. Reference Link

          ShowHide Related Items >><<
          AKUS Akouos
          $14.52 /

          +0.66 (+4.76%)

          AKUS Akouos
          $14.52 /

          +0.66 (+4.76%)

          04/05/21
          Akouos management to meet virtually with BTIG
          03/30/21 BofA
          Akouos downgraded to Neutral at BofA on OTOF IND filing delay
          03/30/21 BofA
          Akouos downgraded to Neutral from Buy at BofA
          08/13/20 Piper Sandler
          Akouos gearing up for 'busy' couple of years, says Piper Sandler
          AKUS Akouos
          $14.52 /

          +0.66 (+4.76%)

          • 26
            Jun
          Hot Stocks
          Air France-KLM, China Eastern Airlines extend scope of partnership » 18:41
          04/12/21
          04/12
          18:41
          04/12/21
          18:41
          AFLYY

          Air France-KLM

          $6.28 /

          -0.225 (-3.46%)

          In the context of the…

          In the context of the participation of China Eastern Airlines to the share capital increase of Air France-KLM, both airline groups have decided to extend the scope of their partnership through: an intensified commercial cooperation and an extended collaboration to noncommercial related activities, and; an increased footprint on the Beijing market, with the Paris-Beijing and Amsterdam-Beijing routes joining the current Joint Venture existing between Air France-KLM and China Eastern Airlines when conditions are satisfied.

          ShowHide Related Items >><<
          AFLYY Air France-KLM
          $6.28 /

          -0.225 (-3.46%)

          AFLYY Air France-KLM
          $6.28 /

          -0.225 (-3.46%)

          03/23/21 Citi
          Citi opens '90-day negative Catalyst Watc' on Air France-KLM
          03/15/21 UBS
          Air France-KLM price target raised to EUR 4.35 from EUR 4.15 at UBS
          02/22/21 Deutsche Bank
          Air France-KLM price target lowered to EUR 2.70 from EUR 3.50 at Deutsche Bank
          02/16/21 Bernstein
          Air France-KLM downgraded to Underperform from Market Perform at Bernstein
          AFLYY Air France-KLM
          $6.28 /

          -0.225 (-3.46%)

          Hot Stocks
          Vasta Platform CFO Clovis Poggetti Junior resigns, Bruno Giardino to succeed » 18:30
          04/12/21
          04/12
          18:30
          04/12/21
          18:30
          VSTA

          Vasta Platform

          $9.30 /

          +0.13 (+1.42%)

          Vasta Platform announced…

          Vasta Platform announced the resignation for personal reasons of Clovis Poggetti Junior as its CFO and investor relations officer and the appointment of Bruno Giardino to serve as the company's CFO and investor relations officer. Clovis Poggetti Junior will continue in the company until April 23, during which period he will transfer his activities to Bruno Giardino. Giardino joins the company after having served as the investor relations officer for the company's parent company, Cogna Educacao S.A., since March 2020.

          ShowHide Related Items >><<
          VSTA Vasta Platform
          $9.30 /

          +0.13 (+1.42%)

          VSTA Vasta Platform
          $9.30 /

          +0.13 (+1.42%)

          12/17/20 Scotiabank
          Vasta Platform initiated with an Outperform at Scotiabank
          08/25/20 UBS
          Vasta Platform initiated with a Buy at UBS
          08/25/20 Morgan Stanley
          Vasta Platform initiated with an Overweight at Morgan Stanley
          08/25/20 BofA
          Vasta Platform initiated with a Buy at BofA
          VSTA Vasta Platform
          $9.30 /

          +0.13 (+1.42%)

          • 31
            Jul
          Hot Stocks
          Safeguard Scientifics exits ownership of stake in Zipnosis » 18:29
          04/12/21
          04/12
          18:29
          04/12/21
          18:29
          SFE

          Safeguard Scientifics

          $6.45 /

          -0.155 (-2.35%)

          The company states:…

          The company states: "Safeguard Scientifics announced the exit of our ownership interest in Zipnosis. Safeguard received $3.3M of initial cash proceeds and a preferred equity interest in Bright Health Group, a national integrated healthcare company. The majority of the consideration we received in the transaction is reflected in this preferred equity interest. Additional cash proceeds may be received from the final determinations of net working capital and the resolution of various escrow contingencies. Safeguard will report a gain on the sale of the Zipnosis ownership interest for the quarter ended March 31, 2021, based on the total value received from the transaction."

          ShowHide Related Items >><<
          SFE Safeguard Scientifics
          $6.45 /

          -0.155 (-2.35%)

          On The Fly
          Fly Intel: After-Hours Movers » 18:25
          04/12/21
          04/12
          18:25
          04/12/21
          18:25
          MFNC

          Mackinac Financial

          $13.26 /

          -0.23 (-1.70%)

          , RILY

          B. Riley Financial

          $60.92 /

          -0.51 (-0.83%)

          , OTIC

          Otonomy

          $2.21 /

          -0.015 (-0.67%)

          , ZUO

          Zuora

          $16.48 /

          +0.045 (+0.27%)

          , SLP

          Simulations Plus

          $63.41 /

          +1.45 (+2.34%)

          , FBIO

          Fortress Biotech

          $5.47 /

          +0.02 (+0.37%)

          , NI

          NiSource

          $24.74 /

          +0.045 (+0.18%)

          , SCKT

          Socket Mobile

          $7.17 /

          -0.69 (-8.78%)

          , CHWY

          Chewy

          $84.02 /

          +0.03 (+0.04%)

          ShowHide Related Items >><<
          ZUO Zuora
          $16.48 /

          +0.045 (+0.27%)

          SLP Simulations Plus
          $63.41 /

          +1.45 (+2.34%)

          SCKT Socket Mobile
          $7.17 /

          -0.69 (-8.78%)

          RILY B. Riley Financial
          $60.92 /

          -0.51 (-0.83%)

          OTIC Otonomy
          $2.21 /

          -0.015 (-0.67%)

          NI NiSource
          $24.74 /

          +0.045 (+0.18%)

          MFNC Mackinac Financial
          $13.26 /

          -0.23 (-1.70%)

          FBIO Fortress Biotech
          $5.47 /

          +0.02 (+0.37%)

          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          MFNC Mackinac Financial
          $13.26 /

          -0.23 (-1.70%)

          RILY B. Riley Financial
          $60.92 /

          -0.51 (-0.83%)

          OTIC Otonomy
          $2.21 /

          -0.015 (-0.67%)

          02/22/21 Piper Sandler
          Otonomy price target lowered to $5 from $10 at Piper Sandler
          12/18/20 H.C. Wainwright
          Otonomy price target raised to $10 from $9 at H.C. Wainwright
          12/17/20 Piper Sandler
          Piper says Otonomy's OTO-413 appears active, peak sales 'not accounted for'
          11/04/20 Piper Sandler
          Piper Sandler likes risk/reward on Otonomy ahead of two readouts by year-end
          ZUO Zuora
          $16.48 /

          +0.045 (+0.27%)

          04/08/21 Berenberg
          Zuora initiated with a Buy at Berenberg
          02/24/21 Jefferies
          Zuora price target raised to $17 from $13 at Jefferies
          12/04/20 Canaccord
          Zuora risk/reward attractive into next year, says Canaccord
          06/29/20 Goldman Sachs
          Zuora price target raised to $11 from $10 at Goldman Sachs
          SLP Simulations Plus
          $63.41 /

          +1.45 (+2.34%)

          01/12/21
          Fly Intel: Top five analyst downgrades
          01/12/21 Craig-Hallum
          Simulations Plus downgraded to Hold from Buy at Craig-Hallum
          01/12/21 Oppenheimer
          Simulations Plus price target raised to $85 from $79 at Oppenheimer
          11/25/20 Taglich Brothers
          Simulations Plus upgraded to Buy from Speculative Buy at Taglich Brothers
          FBIO Fortress Biotech
          $5.47 /

          +0.02 (+0.37%)

          04/05/21 B. Riley
          Fortress Biotech price target raised to $9 from $8 at B. Riley
          02/17/21 Dawson James
          Fortress Biotech price target raised to $21 from $16 at Dawson James
          12/14/20 Benchmark
          Decision looms on Fortress' Caelum after partner Alexion bought, says Benchmark
          10/13/20 B. Riley
          Fortress Biotech weakness on Avenue CRL overblown, says B. Riley Securities
          NI NiSource
          $24.74 /

          +0.045 (+0.18%)

          03/22/21 UBS
          NiSource upgraded to Buy from Neutral at UBS
          01/28/21 Goldman Sachs
          NiSource downgraded to Neutral from Buy at Goldman Sachs
          11/18/20 Barclays
          NiSource upgraded to Overweight from Equal Weight at Barclays
          10/19/20 BofA
          NiSource upgraded to Buy from Neutral at BofA
          SCKT Socket Mobile
          $7.17 /

          -0.69 (-8.78%)

          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          04/05/21 Evercore ISI
          Chewy assumed with an Outperform at Evercore ISI
          03/31/21 Wolfe Research
          Chewy initiated with a Peer Perform at Wolfe Research
          03/31/21 Wedbush
          Chewy price target raised to $100 from $90 at Wedbush
          03/31/21 Jefferies
          Chewy price target raised to $105 from $100 at Jefferies
          ZUO Zuora
          $16.48 /

          +0.045 (+0.27%)

          SLP Simulations Plus
          $63.41 /

          +1.45 (+2.34%)

          SCKT Socket Mobile
          $7.17 /

          -0.69 (-8.78%)

          RILY B. Riley Financial
          $60.92 /

          -0.51 (-0.83%)

          OTIC Otonomy
          $2.21 /

          -0.015 (-0.67%)

          NI NiSource
          $24.74 /

          +0.045 (+0.18%)

          FBIO Fortress Biotech
          $5.47 /

          +0.02 (+0.37%)

          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          • 20
            Apr
          • 08
            Apr
          • 13
            Jan
          • 17
            Sep
          • 06
            Aug
          • 09
            Jul
          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          ZUO Zuora
          $16.48 /

          +0.045 (+0.27%)

          SCKT Socket Mobile
          $7.17 /

          -0.69 (-8.78%)

          RILY B. Riley Financial
          $60.92 /

          -0.51 (-0.83%)

          OTIC Otonomy
          $2.21 /

          -0.015 (-0.67%)

          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          ZUO Zuora
          $16.48 /

          +0.045 (+0.27%)

          SLP Simulations Plus
          $63.41 /

          +1.45 (+2.34%)

          FBIO Fortress Biotech
          $5.47 /

          +0.02 (+0.37%)

          CHWY Chewy
          $84.02 /

          +0.03 (+0.04%)

          Conference/Events
          Morgan Stanley IT hardware analyst to hold analyst/industry conference call » 18:09
          04/12/21
          04/12
          18:09
          04/12/21
          18:09
          DELL

          Dell Technologies

          $93.47 /

          -0.415 (-0.44%)

          IT Hardware Analyst…

          IT Hardware Analyst Huberty, along with Sam Burd, President of Client Solutions Group at Dell, discuss the future of work on an Analyst/Industry conference call.

          ShowHide Related Items >><<
          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          04/08/21 Morgan Stanley
          Dell Technologies price target raised to $107 from $98 at Morgan Stanley
          04/07/21 Deutsche Bank
          Dell Technologies price target raised to $100 from $94 at Deutsche Bank
          02/26/21 JPMorgan
          Dell Technologies price target raised to $98 from $90 at JPMorgan
          02/26/21 Credit Suisse
          Dell Technologies price target raised to $80 from $70 at Credit Suisse
          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          DELL Dell Technologies
          $93.47 /

          -0.415 (-0.44%)

          Get Full Fly Access

          Breaking market intelligence sent straight to you
          Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
          Up-to-date information on important industry events
          Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
          News focused on the companies in your portfolio
          Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.